Comprehensive genomic profiling (CGP) is ushering in an era of precision medicine by making it easier to treat tumors in a targeted manner. Check out 10 leading specialists providing these game-changing services. As increasingly targeted cancer treatments enter the market, demand is growing for ways to quickly learn which patients…

Originally aired: February 2, 2023Time: 9:30 am PT, 12:30 pm ET, 18:30 CET VIEW NOW Science has come quite a long way since the early days of genetic testing over 60 years ago. Our greater understanding of human genetics combined with advanced genomic technologies has allowed researchers to scrutinize numerous genes at once…

View eBook    On June 4th 2022 Illumina hosted a networking event at the American Society of Clinical Oncology (ASCO) entitled “Unlocking Precision Medicine The Transformational Impact of Comprehensive Genomic Profiling (CGP)”. A panel of leading oncologists from academic research institutions and community practices were invited to discuss about the…

Kevin KeeganVP and General Manager, OncologyIllumina Phil Febbo, MDChief Medical OfficerIllumina David Bartlett, MDChairAllegheny Health Network (AHN) Cancer Institute Sandip Patel, MDAssociate Professor of MedicineUniversity of California, San Diego Rachel Sanborn, MDMedical OncologistEarle A. Chiles Research InstituteProvidence Cancer Institute Broadcast Date: September 20, 2022Time: 8:00 am PT, 11:00 am ET, 17:00 CET…

 Sponsored By:     Host: Chris Anderson, EIC, Clinical OMICs Guest: Dr. Sandip Patel, Medical Oncologist, University of California, San Diego In this episode Chris Anderson and Dr. Sandip Patel will examine the growing number of treatments targeted at specific molecular profiles including how broad-based, pan-cancer testing can uncover…

Leading diagnostics developers and lab services companies announced the mid-November launch of the Access to Comprehensive Genomic Profiling Coalition (ACGP), whose mission is to advocate for the effectiveness of comprehensive genomic profiling (CGP) in advanced cancer care. Specifically, ACGP aims to advocate for broader coverage of these tests with both…

Seven leading diagnostics developers and lab services companies today announced the launch of the Access to Comprehensive Genomic Profiling Coalition (ACGP), whose mission is to advocate for the effectiveness of comprehensive genomic profiling (CGP) in advanced cancer care. Specifically, ACGP aims to advocate for broader coverage of these tests with…

National community oncology care network, OneOncology and molecular information company, Foundation Medicine have announced a new joint initiative intended to help physicians unlock the potential of precision oncology through comprehensive genomic profiling (CGP) and research. The partnership will empower physicians across OneOncology’s nearly 170 community oncology care sites to drive…

REGISTER NOW Broadcast Date: February 9, 2021Time: 8:00 am PT, 11:00 am ET, 17:00 CET The number of targeted therapies and the complexity of biomarker detection linked to these therapies has grown over the last decade. To accommodate it, the drug development process must also evolve. In this Clinical OMICs…

When it comes to studying and treating cancer, scientists and clinicians often think of applying two key areas of knowledge: the immune system and genomics. The combination of those fields—immunogenomics—is not quite a new field, but it is on the rise. Even in 2015, Robert Holt, PhD, scientific co-director of…

Using large proteogenomic datasets, novel renal cell carcinoma (RCC) biomarkers were found in a new study led by University of Michigan Health Rogel Cancer Center researchers. The team carried out integrative analysis of datasets from both non-clear cell and clear cell RCC. Their findings should improve researchers’ ability to diagnose subtypes…

Oxford Nanopore and Genomics England are teaming up to sequence up to 7,500 samples from people with a range of genetic or suspected genetic disorders to improve diagnostic outcomes in rare diseases. Building on Genomics England’s landmark 100,000 Genomes Project, this effort also aims to develop an accredited lab workflow…

Metabolomics-focused life sciences company Metabolon and genomic medicine organization Genomics England announced they will partner to advance the characterization of hundreds of rare diseases with the goal of advancing rare disease diagnosis. Metabolon will generate metabolomic data for more than 7,000 participants of the 100,000 Genome Project, one of the…

Oncology-focused real-world evidence (RWE) company ConcertAI and molecular science and technology company Caris Life Sciences announced they will develop a clinico-genomic data platform that combines comprehensive molecular profiling data with reference-standard clinical data to enable precision oncology research. The partnership expands on an agreement reached by the companies in January…

Lung cancer is the second most commonly diagnosed cancer worldwide, after breast cancer, with over 2.2 million new cases recorded in 2020 by the World Health Organization’s International Agency for Research on Cancer. It also accounted for nearly 1.8 million deaths in that year, making it the leading cause of cancer…